Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07029243 · ClinicalTrials.gov registry record · NA
Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis
A NA study, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07029243 is a NA study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 100 participants.
The verdict
NCT07029243, a NA study, has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Frailty and muscle health are important for patients with chronic liver disease. This study looks at the use of a digital prehabilitation app (HEAL-ME) plus creatine and whey protein combination supplementation on maintaining muscle health in patients with liver disease. The investigators anticipate that this combination of supplementation and nutrition/exercise prehabilitation app will maintain muscle health in patients with liver disease.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Whey protein supplementation
- BEHAVIORAL HEAL-ME digital app
- DIETARY_SUPPLEMENT Creatine supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-04 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07029243
The ClinicalTrials.gov registry entry for NCT07029243 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT07029243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07029243 about?
NCT07029243 is a clinical study titled "Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis". Frailty and muscle health are important for patients with chronic liver disease. This study looks at the use of a digital prehabilitation app (HEAL-ME) plus creatine and whey protein combination supplementation on maintaining muscle health in patients with liver disease. The investigators anticipate...
What is the current status of trial NCT07029243?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-04. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07029243?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Whey protein supplementation (DIETARY_SUPPLEMENT), HEAL-ME digital app (BEHAVIORAL), Creatine supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07029243?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.